Breast cancer cells interact with osteoblasts to support osteoclast formation RJ Thomas, TA Guise, JJ Yin, J Elliott, NJ Horwood, TJ Martin, ... Endocrinology 140 (10), 4451-4458, 1999 | 677 | 1999 |
Alarmins: awaiting a clinical response JK Chan, J Roth, JJ Oppenheim, KJ Tracey, T Vogl, M Feldmann, ... The Journal of clinical investigation 122 (8), 2711-2719, 2012 | 616 | 2012 |
Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells NJ Horwood, J Elliott, TJ Martin, MT Gillespie Endocrinology 139 (11), 4743-4746, 1998 | 568 | 1998 |
Activated T lymphocytes support osteoclast formation in vitro NJ Horwood, V Kartsogiannis, JMW Quinn, E Romas, TJ Martin, ... Biochemical and biophysical research communications 265 (1), 144-150, 1999 | 497 | 1999 |
Interleukin-18 (interferon-γ–inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-γ to inhibit … N Udagawa, NJ Horwood, J Elliott, A Mackay, J Owens, H Okamura, ... The Journal of experimental medicine 185 (6), 1005, 1997 | 462 | 1997 |
TNF-α promotes fracture repair by augmenting the recruitment and differentiation of muscle-derived stromal cells GE Glass, JK Chan, A Freidin, M Feldmann, NJ Horwood, J Nanchahal Proceedings of the National Academy of Sciences 108 (4), 1585-1590, 2011 | 446 | 2011 |
Localization of RANKL (receptor activator of NFκB ligand) mRNA and protein in skeletal and extraskeletal tissues V Kartsogiannis, H Zhou, NJ Horwood, RJ Thomas, DK Hards, ... Bone 25 (5), 525-534, 1999 | 432 | 1999 |
The antiproliferative effect of mesenchymal stem cells is a fundamental property shared by all stromal cells S Jones, N Horwood, A Cope, F Dazzi The Journal of Immunology 179 (5), 2824-2831, 2007 | 331 | 2007 |
Monocytes induce STAT3 activation in human mesenchymal stem cells to promote osteoblast formation V Nicolaidou, MM Wong, AN Redpath, A Ersek, DF Baban, LM Williams, ... PloS one 7 (7), e39871, 2012 | 279 | 2012 |
IL-12 alone and in synergy with IL-18 inhibits osteoclast formation in vitro NJ Horwood, J Elliott, TJ Martin, MT Gillespie The Journal of Immunology 166 (8), 4915-4921, 2001 | 279 | 2001 |
Bruton’s tyrosine kinase is required for TLR2 and TLR4-induced TNF, but not IL-6, production NJ Horwood, TH Page, JP McDaid, CD Palmer, J Campbell, T Mahon, ... The Journal of Immunology 176 (6), 3635-3641, 2006 | 276 | 2006 |
Interleukin 18 inhibits osteoclast formation via T cell production of granulocyte macrophage colony-stimulating factor. NJ Horwood, N Udagawa, J Elliott, D Grail, H Okamura, M Kurimoto, ... The Journal of clinical investigation 101 (3), 595-603, 1998 | 269 | 1998 |
Bruton's tyrosine kinase is required for lipopolysaccharide-induced tumor necrosis factor α production NJ Horwood, T Mahon, JP McDaid, J Campbell, H Mano, FM Brennan, ... The Journal of experimental medicine 197 (12), 1603, 2003 | 223 | 2003 |
Macrophage polarization and bone formation: a review NJ Horwood Clinical reviews in allergy & immunology 51, 79-86, 2016 | 203 | 2016 |
Fibroblastic stromal cells express receptor activator of NF‐κB ligand and support osteoclast differentiation JMW Dr. Quinn, NJ Horwood, J Elliott, MT Gillespie, TJ Martin Journal of Bone and Mineral Research 15 (8), 1459-1466, 2000 | 184 | 2000 |
A novel mechanism for TNF-α regulation by p38 MAPK: involvement of NF-κB with implications for therapy in rheumatoid arthritis J Campbell, CJ Ciesielski, AE Hunt, NJ Horwood, JT Beech, LA Hayes, ... The Journal of Immunology 173 (11), 6928-6937, 2004 | 179 | 2004 |
Secreted frizzled‐related protein‐1 inhibits RANKL‐dependent osteoclast formation KD Häusler, NJ Horwood, Y Chuman, JL Fisher, J Ellis, TJ Martin, ... Journal of Bone and Mineral Research 19 (11), 1873-1881, 2004 | 172 | 2004 |
Inhibition of osteoclast function reduces hematopoietic stem cell numbers in vivo S Lymperi, A Ersek, F Ferraro, F Dazzi, NJ Horwood Blood, The Journal of the American Society of Hematology 117 (5), 1540-1549, 2011 | 165 | 2011 |
Strontium can increase some osteoblasts without increasing hematopoietic stem cells S Lymperi, N Horwood, S Marley, MY Gordon, AP Cope, F Dazzi Blood, The Journal of the American Society of Hematology 111 (3), 1173-1181, 2008 | 165 | 2008 |
Th17 cells, not IL-17+ γδ T cells, drive arthritic bone destruction in mice and humans B Pöllinger, T Junt, B Metzler, UA Walker, A Tyndall, C Allard, S Bay, ... The Journal of Immunology 186 (4), 2602-2612, 2011 | 162 | 2011 |